These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 33142257)
1. Targeted delivery of curcumin in breast cancer cells via hyaluronic acid modified mesoporous silica nanoparticle to enhance anticancer efficiency. Ghosh S; Dutta S; Sarkar A; Kundu M; Sil PC Colloids Surf B Biointerfaces; 2021 Jan; 197():111404. PubMed ID: 33142257 [TBL] [Abstract][Full Text] [Related]
2. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy. Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797 [TBL] [Abstract][Full Text] [Related]
3. Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency. Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111239. PubMed ID: 32806268 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin. Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431 [TBL] [Abstract][Full Text] [Related]
5. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy. Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638 [TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells. Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941 [TBL] [Abstract][Full Text] [Related]
7. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis. Li W; Guo Z; Zheng K; Ma K; Cui C; Wang L; Yuan Y; Tang Y Int J Pharm; 2017 Dec; 534(1-2):71-80. PubMed ID: 28958879 [TBL] [Abstract][Full Text] [Related]
8. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912 [TBL] [Abstract][Full Text] [Related]
9. Host-guest fabrication of dual-responsive hyaluronic acid/mesoporous silica nanoparticle based drug delivery system for targeted cancer therapy. Lu J; Luo B; Chen Z; Yuan Y; Kuang Y; Wan L; Yao L; Chen X; Jiang B; Liu J; Li C Int J Biol Macromol; 2020 Mar; 146():363-373. PubMed ID: 31911174 [TBL] [Abstract][Full Text] [Related]
10. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy. Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution. Ji P; Wang L; Chen Y; Wang S; Wu Z; Qi X Biomater Sci; 2020 Jan; 8(1):462-472. PubMed ID: 31750450 [TBL] [Abstract][Full Text] [Related]
12. Preparation of hyaluronic acid-decorated mixed nanomicelles for targeted delivery of hydrophobic drugs to CD44-overexpressing cancer cells. Soleymani M; Velashjerdi M; Asgari M Int J Pharm; 2021 Jan; 592():120052. PubMed ID: 33159986 [TBL] [Abstract][Full Text] [Related]
13. Amine functionalized cubic mesoporous silica nanoparticles as an oral delivery system for curcumin bioavailability enhancement. Hartono SB; Hadisoewignyo L; Yang Y; Meka AK; Antaresti ; Yu C Nanotechnology; 2016 Dec; 27(50):505605. PubMed ID: 27875331 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-based nano-formulation with mesoporous silica enhances the anticancer efficacy of phloroglucinol against gastrointestinal cancers. Shanmugam L; Venkatasubbu GD; Jayaraman M Int J Biol Macromol; 2024 Apr; 265(Pt 1):130856. PubMed ID: 38490393 [TBL] [Abstract][Full Text] [Related]
15. Mesoporous silica nanoparticles functionalized with hyaluronic acid. Effect of the biopolymer chain length on cell internalization. Nairi V; Magnolia S; Piludu M; Nieddu M; Caria CA; Sogos V; Vallet-Regì M; Monduzzi M; Salis A Colloids Surf B Biointerfaces; 2018 Aug; 168():50-59. PubMed ID: 29456044 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of curcumin silica nanoparticle complexes conjugated with hyaluronic acid on colon cancer cells. Singh SP; Sharma M; Gupta PK Int J Biol Macromol; 2015 Mar; 74():162-70. PubMed ID: 25511568 [TBL] [Abstract][Full Text] [Related]
17. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel. Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047 [No Abstract] [Full Text] [Related]
19. Codelivery of Plasmid and Curcumin with Mesoporous Silica Nanoparticles for Promoting Neurite Outgrowth. Cheng CS; Liu TP; Chien FC; Mou CY; Wu SH; Chen YP ACS Appl Mater Interfaces; 2019 May; 11(17):15322-15331. PubMed ID: 30986029 [TBL] [Abstract][Full Text] [Related]
20. Dual drug release mechanisms through mesoporous silica nanoparticle/electrospun nanofiber for enhanced anticancer efficiency of curcumin. Xu L; Li W; Sadeghi-Soureh S; Amirsaadat S; Pourpirali R; Alijani S J Biomed Mater Res A; 2022 Feb; 110(2):316-330. PubMed ID: 34378328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]